Staff Scientist - Assay Development

Job Location
5200 Illumina Way
San Diego, CA 92122

Job Description


As a Staff Scientist at Illumina, you will drive innovative product development through the application of diverse scientific principles. You will be a leader within a multi-disciplinary team working to create novel, robust products for the Array platforms offered by Illumina. You will lead the Assay development group to conceptualize, develop and optimize high-throughput assays and processes to maintain and expand Illumina’s market share in current and emerging markets.  You will help create genomic analysis tools for use in research, translational science and a variety of applied commercial markets.

Job duties include but are not limited to:

  • In collaboration with Marketing, Sales and Customers, develop a roadmap of biochemical assays and workflows to support the changing market needs.
  • Identify, evaluate, plan, and optimize research ideas leading to new robust assays and chemistries.
  • Identify new opportunities for innovative products using the company’s core technologies.
  • Explore new technologies and identify creative solutions to overcome current limitations.
  • Lead projects and guide technical areas independently. Make decisions involving designing, performing, troubleshooting, analyzing and presenting experiments, ultimately resulting in the commercialization of new products in fast-paced product development environment.
  • Manage goals and budgets within defined target timeframes and make decisions regarding the goals and progress of project / functional teams.
  • Be a strong scientific individual contributor as well as a collaborative team leader and proactive functional manager.
  • Perform equally well as individual contributor, collaborative team member and technical manager depending on project needs, be highly adaptive to changing project scopes and responsibilities.
  • Design, implement, analyze and present experiments to demonstrate feasibility of new methods and efficiently move products through pipeline.
  • Write reports and present results and project assessments to Senior Management
  • Optimize assay conditions to achieve commercial levels of stability, robustness and performance.
  • Perform other duties as assigned.

Education and Experience

  • Ph. D. in the Biological Sciences with 7+ years of post Ph.D.  Industrial experience.
  • Four or more years’ experience leading commercial product development in the domain of Genotyping.
  • Ability to translate corporate goals into executable R&D plans while understanding technical risks, mitigations and alternatives.
  • Demonstrated understanding of automating assays for high throughput applications.
  • Proven record of transferring new products to manufacturing and/or QC in a fast paced biotech environment.
  • Strong background in biochemistry and enzymology with a sound understanding of genetic assay development.
  • Highly motivated, detailed individual with the proven ability to think innovatively toward solving problems effectively and efficiently.
  • Experience with CNV and Methylation desired.
  • Able to work effectively under pressure to meet scheduled deadlines and handle multiple activities simultaneously.
  • Experience managing successful cross functional teams and developing personnel
  • Excellent data analysis  and interpretation skills, programming / scripting abilities a plus
  • Excellent oral and written communication skills required to clearly explain complex issues, progress reports and technical roadmaps to a variety of audiences across functions and levels.
  • Experience with fluorescence image analysis is a plus.
  • Proven physical and surface chemistry understanding of biochemical assay processes a significant benefit.


How to Apply please refer to req 2713BR or email

About Our Organization

All About Us
Headquartered in San Diego, California, Illumina (NASDAQ: ILMN), is a leading developer, manufacturer, and marketer of next generation life science tools and integrated systems for large-scale analysis of genetic variation and biological function. These systems are enabling studies that were not even imaginable just a few years ago, and moving us closer to the realization of personalized medicine. With the innovative advances in our sequencing technologies, we are rapidly impacting the clinical market in areas such as reproductive health and oncology. The expanding Illumina oncology portfolio of next- generation sequencing NGS and microarray technologies is revolutionizing cancer genomics research. Our customers include a broad range of academic, government, pharmaceutical, biotechnology, and other leading institutions around the globe.
lllumina has experienced phenomenal growth from $10 million in revenues in 2002 to over $1.9 billion in 2014. Forbes named Illumina #1 on the 2009 list of 25 Fastest-Growing Technology Companies in the United States, the second time over a three year period that Forbes ranked Illumina #1 on its list of rapidly growing technology companies. Illumina was also named #1 smartest company in the world as part of MIT’s 2014 Technology Review.  As of August 2014, the company had a $24 billion market capitalization.

NIH's Michael Lauer looks at the number of grants, their amount, and funding success rates at the agency for last year.

At Nature, Johns Hopkins' Gundula Bosch describes her graduate program that aims to get doctoral students thinking about the big picture.

Patricia Fara writes about childcare funding, and women in science and science history at NPR.

National Institute of Environmental Health Sciences researchers have visualized the career paths of former postdocs.